Complete/Near Complete Itch Response observed in Patients with Moderate-to-Severe Atopic Dermatitis Initiating Dupilumab: 3-year, Real-World, Interim Data from the PROSE Registry

The above graphical abstract represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, and copyright information, please see the full text online. (see “read the peer-reviewed publication” opposite).